Analysts expect Lannett Company, Inc. (NYSE:LCI) to announce earnings per share (EPS) of $0.68 for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Lannett’s earnings. Lannett reported earnings of $1.06 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 35.8%. The business is scheduled to issue its next quarterly earnings report on Wednesday, February 6th.
According to Zacks, analysts expect that Lannett will report full-year earnings of $2.09 per share for the current year, with EPS estimates ranging from $2.05 to $2.13. For the next fiscal year, analysts forecast that the company will report earnings of $0.98 per share, with EPS estimates ranging from $0.90 to $1.05. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that cover Lannett.
Lannett (NYSE:LCI) last announced its earnings results on Wednesday, November 7th. The company reported $0.44 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.05. The company had revenue of $155.10 million during the quarter, compared to the consensus estimate of $145.79 million. Lannett had a negative net margin of 39.74% and a positive return on equity of 21.32%. The firm’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.60 earnings per share.
Shares of LCI stock traded up $0.10 on Friday, hitting $4.71. The stock had a trading volume of 2,258,496 shares, compared to its average volume of 1,316,603. The company has a market cap of $181.03 million, a P/E ratio of 1.52 and a beta of 2.06. The company has a debt-to-equity ratio of 2.44, a current ratio of 2.87 and a quick ratio of 2.07. Lannett has a 12-month low of $3.33 and a 12-month high of $25.40.
In related news, Director Albert Paonessa III purchased 10,000 shares of Lannett stock in a transaction that occurred on Thursday, December 13th. The stock was bought at an average price of $5.07 per share, for a total transaction of $50,700.00. Following the completion of the transaction, the director now owns 2,086,054 shares in the company, valued at $10,576,293.78. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 12.57% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Legal & General Group Plc grew its position in Lannett by 18.2% during the third quarter. Legal & General Group Plc now owns 78,375 shares of the company’s stock valued at $374,000 after buying an additional 12,050 shares during the period. Teachers Advisors LLC boosted its position in Lannett by 64.9% during the third quarter. Teachers Advisors LLC now owns 95,266 shares of the company’s stock worth $453,000 after purchasing an additional 37,492 shares during the period. BlueMountain Capital Management LLC bought a new position in Lannett during the third quarter worth about $306,000. Paloma Partners Management Co boosted its position in Lannett by 147.8% during the third quarter. Paloma Partners Management Co now owns 41,500 shares of the company’s stock worth $197,000 after purchasing an additional 24,753 shares during the period. Finally, Jane Street Group LLC bought a new position in Lannett during the third quarter worth about $537,000. Institutional investors own 81.75% of the company’s stock.
Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages.
Recommended Story: Asset Allocation and Your Retirement
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.